Atlas Trials

Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib

Clinical trial NCT01562847 · UNKNOWN

Trial details

NCT number
NCT01562847
Sponsor
Seoul St. Mary's Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Myeloid Leukemia
Start date
2011-07-01
Primary completion
2014-06-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.